In this study, we have examined the possible existence of astrocyte regional heterogeneity in thrombin effect on astrocyte stellation. Neonatal astrocytes were cultured for 2 weeks from six different regions of the neonatal rat brain, including the cerebral cortex, hippocampus, brainstem, midbrain, hypothalamus and cerebellum. Culture medium was changed to DMEM containing 8-CPT-cyclic AMP (cAMP) or isoproterenol plus various concentrations of thrombin for 2 hr. Thrombin effectively blocked both cAMP-and isoproterenol-induced cell stellation in a dose-dependent manner in all regional astrocytes except cerebellar astrocytes. RT-PCR analysis showed that thrombin receptor mRNA was expressed in all regional astrocytes, suggesting that cerebellar astrocytes may maintain a unique signaling pathway downstream of the thrombin receptor. KEY WORDS: cell culture, morphology, regional heterogeneity.
Astrocytes in vivo display a process-bearing star-shape as referred to by its name. However, when astrocytes are cultured in vitro, many astrocytes start to maintain flat, fibroblast-like polygonal-shape morphology. Several factors can influence the morphology of cultured astrocytes, including the presence or the absence of neuron [5] or reagents, which can increase intracellular cyclic AMP levels [4, 13] . The presence of fetal bovine serum (FBS) in culture medium has been shown to affect astrocyte morphology [11] . Thrombin, a multifunctional serine protease, has been suggested as it causes forebrain astrocyte flattening in culture [8, 15] .
Here, we have examined the effect of thrombin on the morphological changes of astrocytes derived from six different regions of the neonatal rat brain, and have demonstrated that thrombin can block both cAMP-and isoproterenol-induced astrocyte stellation in all examined regional astrocytes except cerebellar astrocytes.
Astrocytes were cultured from neonatal rats (Sprague-Dawley rats; postnatal day 0-1; n=42) as previously described [18] . Briefly, six different regions of the rat brain, including the cerebral cortex, hippocampus, cerebellum, midbrain (superior and inferior colliculi), brainstem (ponsmedulla) and hypothalamus were isolated, and cultivated in Dulbecco's Modified Eagle's Medium (DMEM, Gibco, NY, U.S.A.) containing 10% fetal bovine serum (Hyclone, Logan, UT, U.S.A.) and penicillin/streptomycin (100 units/ ml, each) for 7-10 days. After the cells became confluent, the cultured flask was shaken overnight on an orbital shaker at a speed of 250 rpm in a 37°C CO 2 incubator. On the next day, the attached astrocytes were dissociated with trypsin-EDTA and re-plated (5 × 10 4 cells/cm 2 ) onto 24 well culture plates (Corning, U.S.A.) containing 12 mm circular glass coverslips. The cells were then maintained for additional 3-5 days before experiments. At this stage, we found that GFAP-positive cells were always greater than 95% in astrocyte cultures derived from six different regions of the brain.
The cells were first maintained in the absence of FBS for 24 hr, and then the culture medium was changed to fresh DMEM containing various concentrations of 8-CPT-cAMP (Biolog Life Science Institute, Bremen, Germany) or isoproterenol (Sigma, St Louis, MO, U.S.A.) in the absence or the presence of thrombin (Sigma; purified from bovine plasma). cAMP-or isoproterenol-induced astrocyte stellation was determined after incubating the cells for 2 hr in a 37°C CO 2 incubator.
Cells were fixed in 4% paraformaldehyde and stained with coomassie blue (0.25% Coomassie brilliant blue, R-250, 50% methanol, and 10% acetic acid), and the levels of stellation among different regional astrocytes were compared using an inverted TMS-F microscope (Nikon). Cells with processes longer than their perinuclear diameters were defined as stellate cells according to the criteria used by Shao et al. [13] . For each coverslip, three randomly chosen fields were counted (about 40-60 cells in each field), and the percentage of stellate cells was determined. Two to three coverslips were included for each time point, and expressed as average ± standard deviation (SD). Student's t-test was used for statistical analysis.
RT-PCR (reverse transcription-polymerase chain reaction) was performed as previously described [9] . In brief, total RNAs were extracted from cultured astrocytes after 24 hr FBS deprivation with a Trizol solution (MRC Inc.). cDNA was synthesized from the prepared RNA by oligo(dT)-priming methods using AMV reverse transcriptase. Two different primer sets were used to amplify either N-terminus (primer set A) or C-terminus (primer set B) of the thrombin receptor, proteinase-activated receptor-1, which was shown to be expressed in cerebral cortical astrocytes [2] . The primer set A corresponds to nucleotides 19-41 and 461-481 (numbered according to GenBank, M81642), and the primer set B corresponds to nucleotides 960-981 and 1438-1461; the primer set A contains an intron in the amplified region [6] . The amplified thrombin receptors were confirmed by restriction mapping analysis.
Previous studies demonstrated that thrombin could block cerebral cortical astrocyte stellation induced by cyclic AMP stimulation [14] . Consistent with these reports, we found that thrombin could also block cAMP-induced (250 µM 8-CPT-cAMP) cerebral cortical astrocyte stellation in a dosedependent manner (Fig. 1 ). In addition, we found that thrombin could block other regional astrocytes, including hippocampal, brainstem, midbrain and hypothalamus astrocytes ( Figs. 1 and 2) . Maximum blockage of astrocyte stellation by thrombin could be achieved at 0.2 U/ml (1 mM) concentration in these regional astrocytes. Interestingly, thrombin was not able to block cAMP-induced stellation in cerebellar astrocytes ( Figs. 1 and 2) .
Since the ineffectiveness of thrombin on cAMP-induced cerebellar astrocyte stellation was unexpected, we further tested the effect of thrombin on cerebellar astrocyte stellation induced by another reagent. For this purpose, we used isoproterenol, which is a well-known factor to induce astrocyte stellation [13] . As in cAMP experiments, 0.2 U/ml thrombin effectively blocked isoproterenol-induced astrocyte stellation in all regional astrocytes except cerebellar astrocytes ( Fig. 3 ), suggesting that cerebellar astrocytes may maintain a unique structural plasticity as compared to other regional astrocytes.
Further, to test whether the ineffectiveness of thrombin on cerebellar astrocyte stellation was due to lack of thrombin receptor expression in these cells, we performed RT-PCR using two different sets of PCR primers to amplify either N-terminus or C-terminus of the thrombin receptor, respectively. The results showed that thrombin receptor mRNAs were well expressed in all examined different regional astrocytes, including cerebellar astrocytes (Fig. 4) .
Regional heterogeneity of astrocytes has recently been noted. For example, Astrocytes cultured from different regions of the brain display different degrees of gap-junction coupling [7] , different rate of uptake in serotonin and glutamate [1] and differential modulation of Na + channel mRNA expression [10] . We have been recently demonstrated the astrocyte regional heterogeneity in morphological changes in response to cyclic AMP stimulation [18] . These highly heterogeneous characteristics of different regional astrocytes suggest specialized role of astrocytes in different regions of the CNS during information processing and brain development. The present study adds another aspect of astrocyte regional heterogeneity in regard to thrombin effect on cAMP-and isoproterenol-induced astrocyte stellation.
Since prothrombin mRNA is expressed in the nervous system [17] , it can be speculated that local control of thrombin activity in different regions of the brain may affect astrocytes as well as neuronal morphology changes in vivo. In this regard, protease nexin 1 (PN-1) , a thrombin-inhibiting serine protease inhibitor has been found to be expressed in the nervous system [12] . PN-1 can inhibit thrombininduced astrocyte flattening [3] by forming irreversible complexes with thrombin. Therefore, the balance of thrombin and PN-1 expression in the nervous system may be an important factor to regulate cell morphology changes during normal physiological changes as well as during brain injury involving the damage of blood brain barrier and the introduction of blood thrombin into the nervous system. Thrombin signaling is mediated by members of a subfamily of G-protein-coupled membrane receptors referred to as proteinase-activated receptors (PAR). It is shown that thrombin binds to the receptor and cleaves it at the N-terminus (an Arg-Ser bond at the extracellular domain) to expose a new N-terminus which functions as a tethered ligand [16] . Synthetic peptides corresponding to the newly created Nterminus of the thrombin receptor could mimic the effect of thrombin in altering the cell morphologies of astrocytes and neuroblastoma cells [3, 14] . The expression of PAR in cerebral cortical astrocytes was previously demonstrated [2, 14] . In this study, we have further demonstrated the expression of PAR-1 mRNAs in other regional astrocytes, including cerebellar astrocytes (Fig. 4) . Assuming that PAR-1 mRNAs are translated in all regional astrocytes, it can be suspected that cerebellar astrocytes may maintain a unique signaling pathway downstream of the thrombin receptor as cerebellar astrocytes are resistant to the thrombin effect on cell morphological changes.
ACKNOWLEDGMENT. This work was supported by grants from the NIH (NS-34877) and Epilepsy Foundation of America. Fig. 3 . The effect of thrombin on isoproterenol-induced astrocyte stellation. Astrocytes were treated with 1 mM isoproterenol alone (CTL) or 1 mM isoproterenol plus 0.2 U/ml thrombin for 2 hr. CC, cerebral cortex; HP, hippocampus; CB, cerebellum; MB, midbrain; BS, brainstem; HT, hypothalamus. Fig. 4 . RT-PCR amplification of the thrombin receptor mRNA from two independently prepared astrocyte cultures corresponding to each brain region (analyzed on 2% agarose gel). Two different PCR primer sets were used to amplify N-terminus, 464 bp, (A) or C-terminus, 502 bp, (B) of the thrombin receptor, respectively. M: 100 bp molecular size marker. BS, brainstem; MB, midbrain; HT, hypothalamus; HP, hippocampus; CB, cerebellum; CC, cerebral cortex.
